Renaissance Capital logo

HOWL News

US IPO Weekly Recap: UFC owner Endeavor Group leads a 7 IPO week

FRF

The IPO market stayed active this past week with seven IPOs raising $1.9 billion. One company withdrew ahead of its expected pricing, specialty insurer The Fortegra Group (FRF). SPAC activity picked up slightly, with three blank check IPOs...read more

Preclinical cancer biotech Werewolf Therapeutics prices upsized IPO at $16 midpoint

Werewolf Therapeutics logo

Werewolf Therapeutics, a preclinical biotech developing immune therapies for cancer, raised $120 million by offering an upsized 7.5 million shares at $16, the midpoint of the $15 to $17 range. The company originally planned to offer 6.3 million shares. At...read more

Preclinical cancer biotech Werewolf Therapeutics sets terms for $100 million IPO

Werewolf Therapeutics logo

Werewolf Therapeutics, a preclinical biotech developing immune therapies for cancer, announced terms for its IPO on Monday. The Cambridge, MA-based company plans to raise $100 million by offering 6.3 million shares at a price range of $15 to $17. At the...read more

US IPO Week Ahead: April closes out with a diverse 7 IPO week

AVAH

Updated Monday, 4/26. With the end of April on the horizon, seven IPOs are currently slated to raise $2.2 billion in the week ahead. The diverse group features a home care provider, a talent agency, and more. Home care provider ...read more